246 related articles for article (PubMed ID: 23179776)
1. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.
Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Schwarz P; Faber J
Endocrine; 2013 Jun; 43(3):626-34. PubMed ID: 23179776
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
[TBL] [Abstract][Full Text] [Related]
3. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure.
Siednienko J; Jankowska EA; Banasiak W; Gorczyca WA; Ponikowski P
Int J Cardiol; 2007 Nov; 122(2):111-6. PubMed ID: 17270295
[TBL] [Abstract][Full Text] [Related]
5. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.
Szabó T; Scherbakov N; Sandek A; Kung T; von Haehling S; Lainscak M; Jankowska EA; Rudovich N; Anker SD; Frystyk J; Flyvbjerg A; Pfeiffer AF; Doehner W
Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):50-6. PubMed ID: 23791298
[TBL] [Abstract][Full Text] [Related]
6. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of serum myostatin for the severity and clinical outcome of heart failure.
Chen P; Liu Z; Luo Y; Chen L; Li S; Pan Y; Lei X; Wu D; Xu D
Eur J Intern Med; 2019 Jun; 64():33-40. PubMed ID: 31056368
[TBL] [Abstract][Full Text] [Related]
8. Association Between 3-Iodothyronamine (T1am) Concentrations and Left Ventricular Function in Chronic Heart Failure.
la Cour JL; Christensen HM; Köhrle J; Lehmphul I; Kistorp C; Nygaard B; Faber J
J Clin Endocrinol Metab; 2019 Apr; 104(4):1232-1238. PubMed ID: 30383216
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
[TBL] [Abstract][Full Text] [Related]
10. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
Stanciu AE; Stanciu MM; Vatasescu RG
Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
[TBL] [Abstract][Full Text] [Related]
11. Correlations between serum intact parathyroid hormone (PTH) and N-terminal-probrain natriuretic peptide levels in elderly patients with chronic heart failure (CHF).
Zhang S; Hu Y; Zhou L; Chen X; Wang Y; Wu J; He H; Gao Y
Arch Gerontol Geriatr; 2015; 60(2):359-65. PubMed ID: 25466512
[TBL] [Abstract][Full Text] [Related]
12. NT-proBNP, IGF-I and survival in patients with chronic heart failure.
Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D
Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209
[TBL] [Abstract][Full Text] [Related]
13. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
14. The relationship between adiponectin, NT-pro-BNP and left ventricular ejection fraction in non-cachectic patients with systolic heart failure: an observational study.
Tengiz İ; Türk UÖ; Alioğlu E; Kırılmaz B; Tamer GS; Tüzün N; Ercan E
Anadolu Kardiyol Derg; 2013 May; 13(3):221-6. PubMed ID: 23376650
[TBL] [Abstract][Full Text] [Related]
15. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
Anker SD; Coats AJ
Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500
[TBL] [Abstract][Full Text] [Related]
16. [Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].
Wang F; Xu ZM; Wang L; Bian WY; Jia X; Duan B; Li W; Li YS
Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):490-4. PubMed ID: 16080835
[TBL] [Abstract][Full Text] [Related]
17. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
O'Donoghue M; Chen A; Baggish AL; Anwaruddin S; Krauser DG; Tung R; Januzzi JL
J Card Fail; 2005 Jun; 11(5 Suppl):S9-14. PubMed ID: 15948094
[TBL] [Abstract][Full Text] [Related]
18. Myocardial
Verschure DO; Lutter R; van Eck-Smit BLF; Somsen GA; Verberne HJ
J Nucl Cardiol; 2018 Jun; 25(3):845-853. PubMed ID: 27858345
[TBL] [Abstract][Full Text] [Related]
19. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.
Karabulut A; Kaplan A; Aslan C; Iltumur K; Toprak G; Toprak N
Acta Cardiol; 2005 Dec; 60(6):631-8. PubMed ID: 16385925
[TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
